ORs and 95% CIs for GSM exposure: increase in risk per increase in log GSM (μW/m2)
| Symptom | OR (95% CI) | Change in –2 log likelihood | OR (95% CI) |
|---|---|---|---|
| Fatigue | 1.39*** (1.14 to 1.70) | 11.74*** | 2.13*** (1.34 to 3.83) |
| Irritability | 1.51*** (1.23 to 1.85) | 19.36*** | 2.58*** (1.61 to 4.12) |
| Irritability (adjusted with age) | 1.47*** (1.20 to 1.81) | – | 2.44*** (1.52 to 3.94) |
| Headaches | 1.43** (1.15 to 1.78) | 12.32*** | 2.28** (1.37 to 3.78) |
| Nausea | 1.38** (1.09 to 1.73) | 8.3** | 2.09** (1.23 to 3.55) |
| Lack of appetite | 1.58** (1.23 to 2.03) | 16.31*** | 2.86*** (1.60 to 5.09) |
| Lack of appetite (adjusted to cellular use) | 1.53** (1.19 to 1.99) | – | 2.68*** (1.48 to 4.84) |
| Trouble sleeping | 1.49*** (1.20 to 1.84) | 16.38*** | 2.49*** (1.52 to 4.08) |
| Trouble sleeping (adjusted to worry to BSs) | 1.64*** (1.22 to 2.19) | – | 3.11*** (1.59 to 6.09) |
| Depression | 1.41*** (1.16 to 1.72) | 13.99*** | 2.22*** (1.42 to 3.48) |
| Concentration | 1.54*** (1.25 to 1.89) | 20.75*** | 2.68*** (1.67 to 4.32) |
| Memory | 1.27** (1.06 to 1.52) | 7.29** | 1.73** (1.14 to 2.60) |
| Skin | 1.24* (1.001 to 1.54) | 4.08* | 1.65* (1.01 to 2.71) |
| Visual | 1.23 * (1.03 to 1.46) | 5.30* | 1.59* (1.06 to 2.40) |
| Vertigo | 1.36** (1.11 to 1.66) | 10.14*** | 2.02** (1.28 to 3.20) |
| Vertigo (adjusted to cellular use) | 1.32** (1.08 to 1.62) | – | 1.91** (1.20 to 3.04) |
| Vascular | 1.32* (1.05 to 1.64) | 6.30* | 1.88* (1.12 to 3.14) |
| Hearing | 0.96 (0.80 to 1.15) | 0.90 (0.59 to 1.37) | |
| Walking | 0.95 (0.78 to 1.15) | 0.88 (0.57 to 1.37) |
Changes in –2 log likelihood are also shown. The third column represents the ORs for a 10-fold increase in GSM (log10 GSM).
*p<0.05; **p<0.01; ***p<0.001.
BS, base station; GSM, Global System for Mobile Communication.